DEA schedule
Is baclofen a controlled substance?
Federal schedule for baclofen from the FDA NDC directory, checked against the DEA controlled substances list.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
No. Baclofen is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and baclofen is not on the DEA controlled substances list.
Run it in Rivvi
Which 2027 plans near you dropped or restricted baclofen?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Schedule check
| Source | What it lists |
|---|---|
| FDA NDC directory | 233 prescription listings from 65 labelers, none with a DEA schedule |
| DEA controlled substances list | baclofen is not on the list |
Baclofen NDC listings
| NDC | Product | Form | Strength | Labeler | DEA schedule |
|---|---|---|---|---|---|
| 52652-6001 | FLEQSUVY | suspension | 5 mg/mL | Azurity Pharmaceuticals, Inc. | None |
| 66794-156 | Gablofen | injection, solution | 1000 ug/mL | Piramal Critical Care Inc | None |
| 66794-157 | Gablofen | injection, solution | 2000 ug/mL | Piramal Critical Care Inc | None |
| 66794-151 | Gablofen | injection, solution | 50 ug/mL | Piramal Critical Care Inc | None |
| 66794-155 | Gablofen | injection, solution | 500 ug/mL | Piramal Critical Care Inc | None |
| 70121-2496 | Lioresal (baclofen) | injection | .05 mg/mL | Amneal Pharmaceuticals LLC | None |
| 64896-077 | LYVISPAH | granule | 10 mg/1 | Amneal Pharmaceuticals LLC | None |
| 87519-003 | LYVISPAH | granule | 10 mg/1 | Anvi Pharmaceuticals Inc | None |
| 64896-078 | LYVISPAH | granule | 20 mg/1 | Amneal Pharmaceuticals LLC | None |
| 64896-076 | LYVISPAH | granule | 5 mg/1 | Amneal Pharmaceuticals LLC | None |
| 69528-302 | OZOBAX DS | solution | 10 mg/5mL | Rosemont Pharmaceuticals LLC | None |
| 70511-123 | Baclofen | injection | 1000 ug/mL | MAlA Pharmaceuticals, Inc. | None |
| 72888-146 | BACLOFEN | injection | 1000 ug/mL | Advagen Pharma Limited | None |
| 14789-161 | BACLOFEN | injection | 2000 ug/mL | Nexus Pharmaceuticals LLC | None |
| 72888-147 | BACLOFEN | injection | 2000 ug/mL | Advagen Pharma Limited | None |
| 70511-121 | Baclofen | injection | 50 ug/mL | MAlA Pharmaceuticals, Inc. | None |
| 72888-145 | BACLOFEN | injection | 500 ug/mL | Advagen Pharma Limited | None |
| 25021-680 | Baclofen | injection, solution | 1000 ug/mL | Sagent Pharmaceuticals | None |
| 25021-679 | Baclofen | injection, solution | 2000 ug/mL | Sagent Pharmaceuticals | None |
| 25021-681 | Baclofen | injection, solution | 50 ug/mL | Sagent Pharmaceuticals | None |
| 25021-678 | Baclofen | injection, solution | 500 ug/mL | Sagent Pharmaceuticals | None |
| 17856-0620 | Baclofen | solution | 10 mg/5mL | Atlantic Biologicals Corp. | None |
| 52817-620 | Baclofen | solution | 10 mg/5mL | TRUPHARMA, LLC | None |
| 68134-403 | Baclofen | solution | 10 mg/5mL | Palmetto Pharmaceuticals Inc. | None |
| 72888-466 | Baclofen | solution | 10 mg/5mL | Advagen Pharma Ltd., | None |
| 72888-103 | BACLOFEN | solution | 5 mg/5mL | Advagen Pharma Ltd | None |
| 73352-103 | BACLOFEN | solution | 5 mg/5mL | Trifluent Pharma, LLC | None |
| 52536-600 | Baclofen | suspension | 5 mg/mL | Wilshire Pharmaceuticals, Inc. | None |
| 62559-204 | Baclofen | suspension | 5 mg/mL | ANI Pharmaceuticals, Inc. | None |
| 71225-140 | BACLOFEN | suspension | 5 mg/mL | Slayback Pharma LLC | None |
| 0172-4096 | Baclofen | tablet | 10 mg/1 | Teva Pharmaceuticals USA, Inc. | None |
| 0527-1330 | Baclofen | tablet | 10 mg/1 | Lannett Company, Inc. | None |
| 0603-2406 | Baclofen | tablet | 10 mg/1 | Par Health USA, LLC | None |
| 0615-8466 | BACLOFEN | tablet | 10 mg/1 | NCS HealthCare of KY, LLC dba Vangard Labs | None |
| 0832-1054 | Baclofen | tablet | 10 mg/1 | Upsher-Smith Laboratories, LLC | None |
| 0904-6475 | Baclofen | tablet | 10 mg/1 | Major Pharmaceuticals | None |
| 0904-7552 | BACLOFEN | tablet | 10 mg/1 | Major Pharmaceuticals | None |
| 10135-532 | Baclofen | tablet | 10 mg/1 | Marlex Pharmaceuticals Inc | None |
| 16571-171 | BACLOFEN | tablet | 10 mg/1 | Rising Pharma Holdings, Inc. | None |
| 16714-071 | Baclofen | tablet | 10 mg/1 | Northstar RxLLC | None |
Showing 40 of 233 listings.
Questions
Is baclofen a controlled substance?
No. Baclofen is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and baclofen is not on the DEA controlled substances list.
Is baclofen a narcotic?
No. Baclofen is not on the DEA controlled substances list, so the DEA does not classify it as a narcotic. Its FDA established pharmacologic class is gamma-Aminobutyric Acid-ergic Agonist.
Does this page cover state schedules?
No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.
More on Baclofen
- What is Baclofen used for?FDA label uses
- Generic for GablofenFDA Orange Book
- Generic for LioresalFDA Orange Book
- Generic for OzobaxFDA Orange Book
- Generic for Ozobax DSFDA Orange Book
- Generic for FleqsuvyFDA Orange Book
- Gamma-Aminobutyric Acid-ergic Agonists listFDA drug class
- NDC 52652-6001Baclofen NDC record
- NDC 64896-076Baclofen NDC record
- NDC 64896-077Baclofen NDC record